SpectraCure AB (SPEC) - Total Liabilities

Latest as of December 2025: Skr10.92 Million SEK ≈ $1.17 Million USD

Based on the latest financial reports, SpectraCure AB (SPEC) has total liabilities worth Skr10.92 Million SEK (≈ $1.17 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SPEC net assets growth trend to track the company's year-over-year net asset growth rate.

SpectraCure AB - Total Liabilities Trend (2013–2025)

This chart illustrates how SpectraCure AB's total liabilities have evolved over time, based on quarterly financial data. See SPEC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

SpectraCure AB Competitors by Total Liabilities

The table below lists competitors of SpectraCure AB ranked by their total liabilities.

Company Country Total Liabilities
Springfield Properties Plc
LSE:SPR
UK GBX145.51 Million
Forward Water Technologies Corp
V:FWTC
Canada CA$2.05 Million
Stayble Therapeutics AB
ST:STABL
Sweden Skr1.70 Million
Polledo S.A.
BA:POLL
Argentina AR$427.53 Million
Erech Finance Cahalacha Ltd
TA:EFNC
Israel ILA19.14 Million
Rainbow Polikarbonat Sanayi Ticaret AS
IS:RNPOL
Turkey TL1.38 Billion
Nexoptic Technology Corp
V:NXO
Canada CA$2.25 Million
Moovly Media Inc
V:MVY
Canada CA$5.00 Million

Liability Composition Analysis (2013–2025)

This chart breaks down SpectraCure AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SpectraCure AB (SPEC) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.52 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 1.27 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.12 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.10 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SpectraCure AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SpectraCure AB (2013–2025)

The table below shows the annual total liabilities of SpectraCure AB from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 Skr10.92 Million
≈ $1.17 Million
-22.83%
2024-12-31 Skr14.15 Million
≈ $1.52 Million
-5.53%
2023-12-31 Skr14.97 Million
≈ $1.61 Million
+23.56%
2022-12-31 Skr12.12 Million
≈ $1.30 Million
-18.33%
2021-12-31 Skr14.84 Million
≈ $1.60 Million
+11.42%
2020-12-31 Skr13.32 Million
≈ $1.43 Million
+7.31%
2019-12-31 Skr12.41 Million
≈ $1.34 Million
+208.01%
2018-12-31 Skr4.03 Million
≈ $433.69K
+209.74%
2017-12-31 Skr1.30 Million
≈ $140.02K
-80.46%
2016-12-31 Skr6.66 Million
≈ $716.59K
+542.83%
2015-12-31 Skr1.04 Million
≈ $111.47K
-88.04%
2014-12-31 Skr8.66 Million
≈ $932.40K
+269.23%
2013-12-31 Skr2.35 Million
≈ $252.53K
--

About SpectraCure AB

ST:SPEC Sweden Medical Devices
Market Cap
$1.42 Million
Skr13.15 Million SEK
Market Cap Rank
#30304 Global
#706 in Sweden
Share Price
Skr0.03
Change (1 day)
-3.31%
52-Week Range
Skr0.03 - Skr0.31
All Time High
Skr43.59
About

SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.